6505--667-27-1-075-0004- SHRV - NEW: Compounding sterile hazardous chemotherapy agents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
256-NETWORK CONTRACT OFFICE 16 (36C256)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C25626Q1017
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs, through its 256-Network Contract Office 16, has issued a Combined Synopsis/Solicitation (Solicitation Number: 36C25626Q1017) seeking competitive quotations for the provision of hazardous pharmacy compounding agents, specifically for sterile chemotherapy applications. This procurement is intended to support the Southeast Louisiana Veterans Health Care System (SLVHCS), with the primary place of performance identified as Shreveport, Louisiana.
The purpose of this solicitation is to secure commercial pharmaceutical compounding agents that are essential for the safe and effective preparation of sterile hazardous chemotherapy medications. These agents are critical to the ongoing treatment and care of veterans receiving oncology services within the SLVHCS. The scope of the contract encompasses the supply and timely delivery of these specialized compounding agents, ensuring compliance with all applicable regulatory and safety standards for hazardous drug handling and sterile compounding.
Key requirements for this procurement include the provision of pharmaceutical products that meet the stringent quality and safety standards mandated for hazardous sterile compounding, particularly those used in chemotherapy. Contractors must be capable of supplying these agents in accordance with the specifications outlined in the solicitation and must ensure that all products are manufactured under the NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The Product Service Code associated with this requirement is 6505, which pertains to drugs and biologicals.
The solicitation is being conducted under the authority of FAR Parts 12 and 13, utilizing streamlined procedures for the acquisition of commercial items. This opportunity is unrestricted, allowing for broad competition among qualified vendors. All interested parties are invited to submit electronic quotations by the specified deadline. The solicitation and any incorporated provisions and clauses are governed by the Federal Acquisition Circular (FAC) 2026-01.
Quotations must be submitted electronically to the designated point of contact, Tiffany Conner, at [email protected], no later than 10:00 a.m. Central Standard Time (CST) on Thursday, August 10, 2026. All inquiries and requests for clarification must also be directed to Ms. Conner via email by close of business on August 3, 2026. Phone inquiries will not be accepted.
The contracting entity for this procurement is the 256-Network Contract Office 16, operating under the Department of Veterans Affairs. The primary place of performance is Shreveport, Louisiana, with the delivery location specified as 2400 Canal St, New Orleans, LA 70119, which is the main address for the SLVHCS.
This solicitation represents an opportunity for qualified pharmaceutical manufacturers and suppliers with experience in hazardous sterile compounding to support the critical healthcare needs of veterans in Southeast Louisiana. Contractors should ensure their capabilities align with the requirements for quality, safety, and regulatory compliance as outlined in the solicitation documents.
For further details and to access the full solicitation, interested vendors should refer to the official notice on SAM.gov at https://sam.gov/opp/47fdac2fc4c940b4b19805b4d5b9c98b/view.